EU extends authorization of mpox vaccine to adolescents
Bavarian says mpox vaccine approved by EU regulator for adolescents
Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in adolescents, bolstering the case for using the shot in the 12 to 17 age group to contain an outbreak in parts of Africa.
EU extends authorization of the mpox vaccine to adolescents
The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17. "Although the overall risk of being infected with mpox for the general EU population remains low,
WHO authorizes mpox vaccine, which should ease global access
The World Health Organization announced Friday it has authorized the use of an mpox vaccine, calling it an “important step” in the fight against the disease.   The move could help national
EU drug regulator approves Bavarian's mpox vaccine for adolescents, company says
The EU's drug regulator has approved Bavarian Nordic's mpox vaccine for use in adolescents aged 12 to 17 years, the company said on Thursday, bolstering evidence for using the shot in that age group to contain an outbreak in parts of Africa.
Gavi orders million Mpox vaccine doses from Bavarian Nordic
Gavi, the global vaccine group, announced it will purchase 500,000 doses of Bavarian Nordic’s mpox vaccine. This marks Gavi’s first acquisition of the vaccine to aid in combating an outbreak in parts of Africa.
Bavarian Nordic mpox shot gains approval for adolescents in EU
The European Commission has approved Bavarian Nordic's (OTCPK:BVNRY)(OTCPK:BVNKF) mpox shot for adolescents between 12 and 17 years old. Approval was based on data from a clinical study of more than 300 adolescents and 200 adults that found non-inferior immune responses and similar safety profile between both age groups after two standard doses
Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic
The global vaccine group Gavi will buy 500,000 doses of Bavarian Nordic's mpox vaccine, its first purchase of the shot to help battle an outbreak in parts of Africa, the group said on Wednesday.
Global vaccine alliance GAVI to buy 500,000 doses of mpox vaccine
The global vaccine alliance Gavi says it will buy 500,000 doses of vaccine against mpox to fight outbreaks of the disease in ...
Euronews on MSN2d
Global vaccine donor to buy 500,000 mpox jabs for Africa
Gavi’s purchase puts the total number of vaccines pledged for Africa’s mpox response at more than 4.1 million. European ...
World better positioned against mpox than for COVID: vaccine alliance
Lessons learned from the COVID pandemic have left the world in a much better position to tackle the current mpox epidemic ...
Medscape1d
EMA Broadens Imvanex Vaccine Use to Teens as Mpox Cases Rise
With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.
Patients desperately wait for mpox vaccine at South Kivu Province clinic
Congo's South Kivu province is at the epicenter of the world’s latest mpox outbreak, in what the World Health Organization ...
UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, ...
Mpox: Three ongoing vaccine trials to watch
As the World Health Organization (WHO) has declared mpox an emergency, the Clinical Trials Arena team investigates ongoing ...
Australian Associated Press2d
No risk of mpox vaccine spreading smallpox, experts say
Social media users claim a vaccine approved for use against mpox could cause a smallpox outbreak, but the only thing ...